In addition to liver transplantation to prevent the production of variant TTR [45], patisiran, a short interfering RNA, and inotersen, an antisense oligonucleotide, can reduce the production of TTR and have become available for ATTRv amyloidosis patients [46,47]. This evidence concerns the gene TTR and familial amyloid neuropathy.